We hypothesized that in patients with intracerebral tumours a subcortical metabolical shift may be present when the underlying pathology can, itself, be the epileptogenic focus. We also assumed that by studying the alterations in glucose metabolism beyond the tumour's borders we could identify a modulator area.
- Brain tumour
- Lesional epilepsy
- Subcortical metabolic depression
- [F]fluorodeoxyglucose PET
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging